Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

3 mins

Michael Greenwood, AGS 2022: Femtosecond Lasers and Aberrometry in Cataract Surgery in Glaucoma Patients

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 16th 2022

It was a pleasure to speak with Dr Michael Greenwood (Vance Thompson Vision, Fargo, ND) to find out his thoughts on the applications, advantages and limitations of femtosecond lasers and aberrometry in cataract surgery.

The presentation entitled ‘Femto, Aberrometry, and Multifocality in Glaucoma Patients: Where Do We Stand?’ was presented at the 2022 American Glaucoma Society Annual Meeting, March 03-06, 2022.

Questions: 

  1. What are the potential applications of femtosecond lasers in cataract surgery in glaucoma patients and what are the limitations of this approach? (00:19)
  2. What are the advantages and limitations of intraoperative aberrometry during cataract surgery? (02:02)

Disclosures: Michael Greenwood is a consultant for Avellino, Equinox, Expert Opinion, Ivantis, Nevakar, New World Medical, Ocular Therapeutix, Tarsus.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the virtual AGS 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup